Appetite Hormones in Pediatric Kidney Failure: Ghrelin, PYY, and GLP-1 Across Dialysis and Transplant

Ghrelin, PYY, and GLP-1 levels were altered in pediatric chronic renal failure patients, changing further after dialysis and transplant — explaining the appetite disturbances that affect growth in children with kidney disease.

Arbeiter, Anja K et al.·Nephrology·2009·Moderate Evidenceclinical-trial
RPEP-01451Clinical TrialModerate Evidence2009RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
clinical-trial
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Pediatric CRF patients showed altered ghrelin, PYY3-36, and GLP-1 profiles that changed with dialysis and post-transplant, with appetite hormone disturbances correlating with growth impairment — explaining appetite-growth dysfunction in pediatric kidney disease.

Key Numbers

How They Did This

clinical-trial study.

Why This Research Matters

Relevant for neuropeptides, kidney, weight-loss.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Pediatric CRF patients showed altered ghrelin, PYY3-36, and GLP-1 profiles that changed with dialysis and post-transplant, with appetite hormone distu
Evidence Grade:
moderate evidence.
Study Age:
Published in 2009.
Original Title:
Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation.
Published In:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 24(2), 643-6 (2009)
Database ID:
RPEP-01451

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

Appetite Hormones in Pediatric Kidney Failure: Ghrelin, PYY, and GLP-1 Across Dialysis and Transplant

What was found?

Ghrelin, PYY, and GLP-1 levels were altered in pediatric chronic renal failure patients, changing further after dialysis and transplant — explaining the appetite disturbances that affect growth in children with kidney disease.

Read More on RethinkPeptides

Cite This Study

RPEP-01451·https://rethinkpeptides.com/research/RPEP-01451

APA

Arbeiter, Anja K; Büscher, Rainer; Petersenn, Stephan; Hauffa, Berthold P; Mann, Klaus; Hoyer, Peter F. (2009). Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation.. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 24(2), 643-6. https://doi.org/10.1093/ndt/gfn529

MLA

Arbeiter, Anja K, et al. "Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation.." Nephrology, 2009. https://doi.org/10.1093/ndt/gfn529

RethinkPeptides

RethinkPeptides Research Database. "Ghrelin and other appetite-regulating hormones in paediatric..." RPEP-01451. Retrieved from https://rethinkpeptides.com/research/arbeiter-2009-ghrelin-and-other-appetiteregulating

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.